Why the CNS boom owes its success to breakthroughs in neurological pathologies

Tuesday, September 8, 2026Frankie FattoriniView original

Shifting emphasis from symptoms to biomarkers has bolstered sector confidence in emerging CNS therapies.

Read the full article on the original site.